Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INITIATE: Advate ITI Dosing in Hemophilia A with Inhibitors
NCT06864975Phase 4Recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A. Started Mar 2025; status: recruiting.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT06864975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06864975.